ClinConnect ClinConnect Logo
Search / Trial NCT06638099

Increasing CGM Use Among Patients With T2D

Launched by SAN DIEGO STATE UNIVERSITY · Oct 9, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Diabetes Mellitus Type 2 Continuous Glucose Monitor Fqhc Intervention Health Care Providers Cgm Education

ClinConnect Summary

This clinical trial is studying whether training healthcare professionals can help increase the number of prescriptions for continuous glucose monitors (CGMs) for patients with Type 2 Diabetes (T2D). CGMs are devices that help people monitor their blood sugar levels continuously, which can improve diabetes management. The trial is taking place in healthcare centers that primarily serve Hispanic/Latino patients. Researchers want to find out if better trained healthcare providers will prescribe more CGMs, if using a CGM helps control diabetes better, and what challenges patients face when using these devices.

To participate in the study, you need to be at least 18 years old, diagnosed with Type 2 Diabetes for at least a year, and currently receiving care at one of the participating clinics. You should also be able to communicate in English or Spanish and have a phone. If you join, you will complete surveys about your diabetes management and share your experiences with CGMs over six months. This research aims to improve diabetes care for patients in this community by understanding how training providers can lead to better health outcomes.

Gender

ALL

Eligibility criteria

  • Participant Eligibility:
  • Inclusion:
  • adults 18 years or older,
  • have been diagnosed with T2D at least one year prior to recruitment,
  • are a current patient of one of the three participating Innercare Clinics with no -
  • plans to discontinue their care at Innercare within the next 6 months,
  • can understand and speak in English or Spanish,
  • have telephone access,
  • do not plan to move out of the area within the next 6 months.
  • Exclusion:
  • Plans to move out of the area in the next 6 months
  • Patients with newly diagnose diabetes mellitus (less than one year), diabetes insipidus, diabetes type 1 or gestational diabetes.
  • Provider/Staff Eligibility:
  • Inclusion
  • 18 years or older,
  • able to read and write in English,
  • currently employed at one of the participating Innercare clinics (Brawley, El Centro, Calexico),
  • currently be treating at least one adult patient for T2D, scheduled to complete the CGM toolkit training. Exclusion
  • Personnel without experience providing care to adult patients with T2D in primary care settings.

About San Diego State University

San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.

Locations

El Centro, California, United States

El Centro, California, United States

Patients applied

0 patients applied

Trial Officials

Emily Schmied,, PhD

Principal Investigator

San Diego State University

Shiloh Williams, PhD RN

Principal Investigator

San Diego State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported